Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$7,011,938
in 3 filings, $6.7M under 10b5-1 plans

Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BAKER BROS. ADVISORS LP +$35.0M Director 1 filing
  2. Sibold William John −$6.2M President and CEO sold 6% of stake
  3. Kelley Shannon T −$773K General Counsel sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2017-03-02 Taub Rebecca Chief Medical Officer, EVP R&D Grant or award · Stock Option (Right to Buy) +37,300 37,300
2017-03-02 Schneebaum Marc R Chief Financial Officer Grant or award · Stock Option (Right to Buy) +27,300 27,300
2017-03-02 FRIEDMAN PAUL A Chief Executive Officer Grant or award · Stock Option (Right to Buy) +49,600 49,600
2016-08-11 Levy Richard S Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-07-22 MILLIGAN DAVID V Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-07-22 CRAVES FRED B Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-07-22 BATE KENNETH Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-07-22 Gollust Keith R Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-07-22 CRAVES FRED B Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-07-22 Gollust Keith R Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-07-22 BATE KENNETH Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-07-22 MILLIGAN DAVID V Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2016-07-22 Taub Rebecca Chief Medical Officer, EVP R&D Grant or award +30,626 434,758
2016-07-22 Taub Rebecca Chief Medical Officer, EVP R&D Grant or award · Employee Stock Option (Right to Buy) +153,128 153,128
2016-07-22 FRIEDMAN PAUL A Chief Executive Officer Grant or award +153,128 153,274
2016-07-22 FRIEDMAN PAUL A Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +306,256 306,256
2016-07-22 Schneebaum Marc R Chief Financial Officer Grant or award +24,501 43,809
2016-07-22 Schneebaum Marc R Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +98,002 98,002
2016-07-22 CRAVES FRED B Director Grant or award +296,067 296,067
2016-07-22 CRAVES FRED B Director Grant or award +5,538,474 5,538,474

Page 58 of 82 · 1,629 trades